Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol
Clinical trial NCT01526434 · COMPLETED
Trial details
- NCT number
- NCT01526434
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-01-01
- Primary completion
- 2014-03-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.